Inhibition of Complement Retards Ankylosing Spondylitis Progression

about

Screening for key genes and transcription factors in ankylosing spondylitis by RNA-Seq.

P2860

Q49523074-1EEE3891-E45F-48D6-A65B-43465C2E229D

P2860

Inhibition of Complement Retards Ankylosing Spondylitis Progression

Item

http://www.wikidata.org/entity/Q37307003

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of Complement Retards Ankylosing Spondylitis Progression

@en

Inhibition of Complement Retards Ankylosing Spondylitis Progression.

@nl

type

Item

label

Inhibition of Complement Retards Ankylosing Spondylitis Progression

@en

Inhibition of Complement Retards Ankylosing Spondylitis Progression.

@nl

prefLabel

Inhibition of Complement Retards Ankylosing Spondylitis Progression

@en

Inhibition of Complement Retards Ankylosing Spondylitis Progression.

@nl

P1476

Inhibition of Complement Retards Ankylosing Spondylitis Progression

@en

P2093

Chaoqun Yang

http://www.w3.org/2001/XMLSchema#string

Enjie Xu

http://www.w3.org/2001/XMLSchema#string

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Jianquan Zhao

http://www.w3.org/2001/XMLSchema#string

Long Zhang

http://www.w3.org/2001/XMLSchema#string

Na Wang

http://www.w3.org/2001/XMLSchema#string

Peipei Ding

http://www.w3.org/2001/XMLSchema#string

Qingkai Wang

http://www.w3.org/2001/XMLSchema#string

Xin Zhang

http://www.w3.org/2001/XMLSchema#string

Xuhui Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6

Complement: a key system for immune surveillance and homeostasis

Association of inflammation with raised serum IgA in ankylosing spondylitis

The in-vivo metabolism of C3 in ankylosing spondylitis.

Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Advances in managing ankylosing spondylitis

Complement-targeted therapeutics

Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.

Complement induces a transient increase in membrane permeability in unlysed erythrocytes.

P2888

srep34643

P304

34643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP34643

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Weiguo Hu

Jianfeng Chen

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049251252

http://www.w3.org/2001/XMLSchema#string

P698

27698377

http://www.w3.org/2001/XMLSchema#string

P932

5048143

http://www.w3.org/2001/XMLSchema#string

Inhibition of Complement Retards Ankylosing Spondylitis Progression

about

P2860

P2860

Inhibition of Complement Retards Ankylosing Spondylitis Progression

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P932